CIK 0001832038
- Emerging growth company
Invivyd, Inc.
Sign in to watch- Ticker
- IVVD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851403134
- Phone
- +1 781-819-0080
- Business address
- 205 CHURCH STREET, NEW HAVEN, CT
- Former names
- Adagio Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $86,839
- in 5 filings, $87K under 10b5-1 plans
Net −$86,839. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Andersen Jill −$26K Chief Legal Officer, Secretary sold 10% of stake
- Duke William E. −$16K Chief Financial Officer sold 10% of stake
- Green Julie −$16K Chief Human Resources Officer sold 10% of stake
- Lee Timothy Edward −$16K Chief Commercial Officer sold 9% of stake
- Allen Robert D. III −$14K Chief Scientific Officer sold 9% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-05 | Mayer Howard Director | Grant or award · Stock Option (Right to Buy) | +35,593 | 35,593 | ||
| 2021-08-05 | MCGUIRE TERRANCE Director | Grant or award · Stock Option (Right to Buy) | +35,593 | 35,593 | ||
| 2021-08-05 | Royan Ajay Director | Grant or award · Stock Option (Right to Buy) | +35,593 | 35,593 | ||
| 2021-08-05 | Russo Rene Director | Grant or award · Stock Option (Right to Buy) | +35,593 | 35,593 | ||
| 2021-08-05 | WYZGA MICHAEL S Director | Grant or award · Stock Option (Right to Buy) | +71,186 | 71,186 |
Page 12 of 12 · 225 trades